IgAN

GLASGOW, Scotland – June 6, 2026 AstraZeneca’s rare disease division, Alexion, has reported positive interim Phase III results for...

WELLESLEY HILLS, Mass., June 5, 2026 Climb Bio, Inc. announced the presentation of initial Phase 1 safety data and...

MUMBAI, India, June 2, 2026 Alkem Laboratories has announced the launch of India’s first semaglutide single-shot pre-filled syringes, marking...

GLASGOW, Scotland, June 4, 2026 Otsuka Pharmaceutical Co., Ltd. and Otsuka Pharmaceutical Development & Commercialization, Inc. have announced positive...

BOSTON, June 1, 2026 Vertex Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has accepted its Biologics...

Bagsværd, Denmark & Seattle, USA – October 15, 2025 – In a move strengthening its foothold in immunology and...